[ad_1]
Shares in Ryanair fell 12% on Monday as the low-cost airline said lower air fares and higher costs had led to a 46% drop in its first quarter profits
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...